Bath & Body Works, Inc. (NYSE:BBWI) Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 3.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,158,390 shares of the company’s stock after purchasing an additional 40,868 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.53% of Bath & Body Works worth $36,976,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. First Community Trust NA bought a new position in shares of Bath & Body Works in the second quarter valued at $30,000. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after purchasing an additional 900 shares during the period. Meeder Asset Management Inc. lifted its holdings in shares of Bath & Body Works by 480.3% during the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,436 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Bath & Body Works by 65.4% in the 2nd quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock valued at $72,000 after purchasing an additional 730 shares during the period. Finally, Abich Financial Wealth Management LLC purchased a new position in Bath & Body Works in the 3rd quarter worth about $103,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

BBWI has been the subject of a number of analyst reports. Barclays upped their price objective on shares of Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday, November 26th. Wells Fargo & Company raised their price objective on shares of Bath & Body Works from $32.00 to $38.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 26th. Morgan Stanley cut their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research note on Thursday, November 21st. TD Cowen raised their target price on Bath & Body Works from $40.00 to $42.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, BMO Capital Markets reiterated an “outperform” rating and set a $50.00 price target (down previously from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.

Insiders Place Their Bets

In other news, CEO Gina Boswell bought 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The shares were purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.27% of the company’s stock.

Bath & Body Works Stock Down 1.6 %

NYSE BBWI opened at $36.90 on Wednesday. The company has a 50 day moving average price of $31.33 and a two-hundred day moving average price of $35.30. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a market capitalization of $7.99 billion, a PE ratio of 9.00, a price-to-earnings-growth ratio of 1.40 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same period in the prior year, the company posted $0.48 earnings per share. Bath & Body Works’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.26 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be issued a $0.20 dividend. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.17%. Bath & Body Works’s dividend payout ratio (DPR) is currently 19.51%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.